Skip to main content

Table 1 Clinical study population findings

From: Abnormal shortened diastolic time length at increasing heart rates in patients with abnormal exercise-induced increase in pulmonary artery pressure

  Abnormal exercise PASP Normal exercise PASP P =
N of pts 14 95  
Dilated cardiomyopathy 1 (7%) 8 (8.5%) NS
Aortic stenosis, moderate 3 (21%) 4 (4.2%) < 0.05
Aortic regurgitation, moderate 0 2 (2.1%) NS
Mitral stenosis, moderate 1 (7%) 0 NS
Mitral regurgitation, moderate 4 (29%) 3 (3.2%) < 0.05
Known coronary artery disease 3 (21%) 45 (47.4%) < 0.05
Prior myocardial infarction 1 (7%) 35 (37.6%) < 0.05
Prior percutaneous coronary intervention 2 (14%) 32 (33.7%) NS
Arterial hypertension 7 (50%) 46 (48.4%) NS
Chronic obstructive pulmonary disease 0 18 (18.9%) < 0.05
Diabetes 1 (7%) 20 (22.7%) NS
Effort dyspnea 10 (77%) 39 (41%) < 0.05
Left bundle branch block 3 (21%) 12 (12.6%) NS
Right bundle branch block 0 8 (8.5%) NS
Therapy at the time of test    
β-blockers 7 (50%) 40 (42.1%) NS
Calcium antagonists 3 (21%) 26 (27.4%) NS
Nitrates 1 (7%) 17 (18.3%) NS
ACE inhibitors 5 (36%) 34 (36.6%) NS
Diuretics 4 (29%) 13 (13.7%) NS
At least one medication 10 (71%) 69 (72.6%) NS
  1. Data presented number (%) of patients.
  2. PASP, pulmonary artery systolic pressure